The Food and Drug Administration (FDA) recently issued warning letters to two third-party nonclinical testing laboratories.
The U.S. Food and Drug Administration issued warning letters to two Chinese third-party testing firms on Wednesday, citing ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
The U.S. Food and Drug Administration's (FDA) warning letter to Agena Bioscience, issued on March 21, 2024, marks a significant shift in enforcement priorities, targeting the improper labeling of ...
A drug production facility in Durham run by a Chinese company violated multiple safety regulations, according to the FDA. A ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...
Indian generic manufacturer Zydus Lifesciences was hit with an FDA warning letter on Tuesday after it shipped vitamin B ...
The FDA said the problems “raise concerns about the quality and integrity of data generated by the labs,” which provide third-party testing and validation data services for device firms.
The firms, which provide third-party testing and validation data services to medical device manufacturers, were found to have “pervasive failures” that could lead to faulty data.
The situation began to unravel on July 7, 2023, when Outset Medical announced it had received a warning letter from the FDA. The letter asserted that the company was promoting a Tablo product ...